B
BIOWEG
Bio-based ingredient alternatives to petroleum-based chemicals
About BIOWEG
BIOWEG (formerly Cellulosic Technologies) is a German biotechnology company using precision fermentation and green chemistry to produce high-performance, bio-based and biodegradable ingredients that replace intentionally added microplastics and fossil-derived polymers. The company converts food-industry side streams into high-purity bacterial cellulose and tailors it into functional materials for formulators.
BIOWEG's product families include MicBeads and RheoWeg for cosmetics and personal care, HydroWeg for food and beverages, and AgriWeg for agricultural seed and fertiliser coatings. Its ingredients help formulators comply with the EU restriction on intentionally added synthetic polymer microparticles under REACH. The company operates a demonstration site in Quakenbrück, Germany, and is building a 10,000-tonne-per-year bacterial cellulose production plant in Elsdorf, North Rhine-Westphalia, with first commercial volumes expected in 2028.
Founded in 2019 by Dr Prateek Mahalwar and Srinivas Karuturi, BIOWEG is backed by a Series A led by Axeleo Capital and by grant funding from the European Union and German programmes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Quakenbrück, Germany
- Employees
- 37
- Open positions
- 5
- Dealroom signal
- 92.3/100
- Sub-industry
- Waste Solution, AgriTech
- Sector
- Energy, Biotechnology, Biomaterials, Bacteria, Organic Waste, Synthetic Biology, Alternative Protein, Sustainable Development Goals, EIC
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Dec 2025 | $1.6M | — | SPRIN-D | ↗ |
| SERIES A✓Equity / VC | Sep 2025 | $18M | $70M | EIC Fund · Axeleo Capital · BONVENTURE · NBank Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for BIOWEG is 2.6K monthly website visits, down 29.7% over the last three months. BIOWEG's team grew 60.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
European Innovation Council
SPRIN-D
Series A5 investors entered at this stage
EIC Fund
Axeleo Capital
BONVENTURE
NBank Capital- FJFrank Jenner
Other known investors11 additional known investors
CDL-Paris
La Maison des Startups by LVMH
RootCamp - A SpinLab Incubator
VentureOut
YES!Delft
Creative Destruction Lab
Endless Frontier Labs
Plug and Play
TechQuartier
Up2B Accelerator
X2.0
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BIOWEG on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BIOWEG’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.